Back to Browse Journals » OncoTargets and Therapy » Volume 8 » default

OncoTargets and Therapy


Archive: Volume 8, 2015

Correlation of 18F-fluoroethyl tyrosine positron-emission tomography uptake values and histomorphological findings by stereotactic serial biopsy in newly diagnosed brain tumors using a refined software tool

Lopez WO, Cordeiro JG, Albicker U, Doostkam S, Nikkhah G, Kirch RD, Trippel M, Reithmeier T

OncoTargets and Therapy 2015, 8:3803-3815

Published Date: 17 December 2015

Prognostic and clinicopathological significance of serum interleukin-6 expression in colorectal cancer: a systematic review and meta-analysis

Wang Z, Wu P, Wu D, Zhang ZG, Hu GM, Zhao S, Lai YC, Huang J

OncoTargets and Therapy 2015, 8:3793-3801

Published Date: 16 December 2015

The role of CD44 in epithelial–mesenchymal transition and cancer development

Xu HX, Tian YJ, Yuan X, Wu H, Liu Q, Pestell RG, Wu KM

OncoTargets and Therapy 2015, 8:3783-3792

Published Date: 16 December 2015

Impact of age on the prognosis after liver transplantation for patients with hepatocellular carcinoma: a single-center experience

Wang P, Wang C, Li H, Shi B, Wang J, Zhong L

OncoTargets and Therapy 2015, 8:3775-3781

Published Date: 16 December 2015

Epidermal growth factor, latrophilin, and seven transmembrane domain-containing protein 1 marker, a novel angiogenesis marker

Serban F, Artene SA, Georgescu AM, Purcaru SO, Tache DE, Alexandru O, Dricu A

OncoTargets and Therapy 2015, 8:3767-3774

Published Date: 16 December 2015

Role of NSC319726 in ovarian cancer based on the bioinformatics analyses

Xue J, Yang G, Ding H, Wang P, Wang CH

OncoTargets and Therapy 2015, 8:3757-3765

Published Date: 15 December 2015

Prognostic impact of initial maximum standardized uptake value of 18F-FDG PET/CT on treatment response in patients with metastatic lung adenocarcinoma treated with erlotinib

Kus T, Aktas G, Sevinc A, Kalender ME, Yilmaz M, Kul S, Oztuzcu S, Oktay C, Camci C

OncoTargets and Therapy 2015, 8:3749-3756

Published Date: 15 December 2015

GIT1 is a novel prognostic biomarker and facilitates tumor progression via activating ERK/MMP9 signaling in hepatocellular carcinoma

Chen J, Yang P, Yang J, Wen Z, Zhang B, Zheng X

OncoTargets and Therapy 2015, 8:3731-3742

Published Date: 15 December 2015

Risks on N-acetyltransferase 2 and bladder cancer: a meta-analysis

Zhu Z, Zhang J, Jiang W, Zhang X, Li Y, Xu X

OncoTargets and Therapy 2015, 8:3715-3720

Published Date: 11 December 2015

Non-leukemic myeloid sarcoma involving the vulva, vagina, and cervix: a case report and literature review

Yu Y, Qin X, Yan S, Wang W, Sun Y, Zhang M

OncoTargets and Therapy 2015, 8:3707-3713

Published Date: 10 December 2015

Correlations between plasma endothelin-1 levels and breakthrough pain in patients with cancer

Yan XB, Peng TC, Huang D

OncoTargets and Therapy 2015, 8:3703-3706

Published Date: 8 December 2015

Profile of nintedanib in the treatment of solid tumors: the evidence to date

Awasthi N, Schwarz RE

OncoTargets and Therapy 2015, 8:3691-3701

Published Date: 8 December 2015

Association between MDM2 SNP309 T>G polymorphism and the risk of bladder cancer: new data in a Chinese population and an updated meta-analysis

Xie LG, Sun Y, Chen T, Tian DW, Li YJ, Zhang Y, Ding N, Shen ZH, Xu H, Nian XW, Sha N, Han RF, Hu HL, Wu CL

OncoTargets and Therapy 2015, 8:3679-3690

Published Date: 7 December 2015

Crosstalk with cancer-associated fibroblasts induces resistance of non-small cell lung cancer cells to epidermal growth factor receptor tyrosine kinase inhibition

Choe C, Shin YS, Kim C, Choi SJ, Lee J, Kim SY, Cho YB, Kim J

OncoTargets and Therapy 2015, 8:3665-3678

Published Date: 7 December 2015

Echinacoside induces apoptotic cancer cell death by inhibiting the nucleotide pool sanitizing enzyme MTH1

Dong L, Wang H, Niu J, Zou M, Wu N, Yu D, Wang Y, Zou Z

OncoTargets and Therapy 2015, 8:3649-3664

Published Date: 8 December 2015

Downregulation of microRNA-132 by DNA hypermethylation is associated with cell invasion in colorectal cancer

Qin J, Ke J, Xu JF, Wang FR, Zhou YL, Jiang YS, Wang ZW

OncoTargets and Therapy 2015, 8:3639-3648

Published Date: 7 December 2015

First-line chemotherapy in patients with metastatic gastroenteropancreatic neuroendocrine carcinoma

Bongiovanni A, Riva N, Ricci M, Liverani C, La Manna F, De Vita A, Foca F, Mercatali L, Severi S, Amadori D, Ibrahim T

OncoTargets and Therapy 2015, 8:3613-3619

Published Date: 3 December 2015

Inhibitive effects of 15-deoxy-Δ12,14-prostaglandin J2 on hepatoma-cell proliferation through reactive oxygen species-mediated apoptosis

Chen K, Dai W, Wang F, Xia Y, Li J, Li S, Liu T, Zhang R, Wang J, Lu W, Zhou Y, Yin Q, Zheng Y, Abudumijiti H, Chen R, Lu J, Zhou Y, Guo C

OncoTargets and Therapy 2015, 8:3585-3593

Published Date: 1 December 2015

The relationship between UGT1A1 gene polymorphism and irinotecan effect on extensive-stage small-cell lung cancer

Xiao XG, Xia S, Zou M, Mei Q, Zhou L, Wang SJ, Chen Y

OncoTargets and Therapy 2015, 8:3575-3583

Published Date: 3 December 2015

A metastatic colon adenocarcinoma harboring BRAF V600E has a durable major response to dabrafenib/trametinib and chemotherapy

Williams CB, McMahon C, Ali SM, Abramovitz M, Williams KA, Klein J, McKean H, Yelensky R, George Jr TJ, Elvin JA, Soman S, Lipson D, Chmielecki J, Morosini D, Miller VA, Stephens PJ, Ross JS, Leyland-Jones B

OncoTargets and Therapy 2015, 8:3561-3564

Published Date: 1 December 2015

Inhibition of TGF-β signaling with halofuginone can enhance the antitumor effect of irradiation in Lewis lung cancer

Lin RL, Yi S, Gong LL, Liu WS, Wang P, Liu NB, Zhao LJ, Wang P

OncoTargets and Therapy 2015, 8:3549-3559

Published Date: 2 December 2015

Ultrasound-guided RNA interference targeting HIF-1 alpha improves the effects of transarterial chemoembolization in rat liver tumors

Chen CS, Zhao Q, Qian S, Li HL, Guo CY, Zhang W, Yan ZP, Liu R, Wang JH

OncoTargets and Therapy 2015, 8:3539-3548

Published Date: 27 November 2015

The XRCC1 Arg194Trp polymorphism is significantly associated with lung adenocarcinoma: a case-control study in an Eastern European Caucasian group

Cătană A, Pop M, Hincu BD, Pop IV, Petrişor FM, Porojan MD, Popp RA

OncoTargets and Therapy 2015, 8:3533-3538

Published Date: 27 November 2015

Relationship between high-mobility group box 1 overexpression in ovarian cancer tissue and serum: a meta-analysis

Wang HP, Li ZJ, Sun YL, Xu ZF, Han JJ, Song B, Song WT, Qin C, Yin L

OncoTargets and Therapy 2015, 8:3523-3531

Published Date: 27 November 2015

The association between osteopontin and survival in non-small-cell lung cancer patients: a meta-analysis of 13 cohorts

Wang Y, Yang J, Liu H, Bi JR, Liu Y, Chen YY, Cao JY, Lu YJ

OncoTargets and Therapy 2015, 8:3513-3521

Published Date: 26 November 2015

Ability of PITX2 methylation to predict survival in patients with prostate cancer

Li JZ, Zhang Y, Wen B, Li M, Wang YJ

OncoTargets and Therapy 2015, 8:3507-3512

Published Date: 24 November 2015

Expression of CPEB4 in invasive ductal breast carcinoma and its prognostic significance

Sun HT, Wen X, Han T, Liu ZH, Li SB, Wang JG, Liu XP

OncoTargets and Therapy 2015, 8:3499-3506

Published Date: 26 November 2015

Effect of gyromagnetic fields on human prostatic adenocarcinoma cells

Lei H, Xu Y, Guan R, Li M, Hui Y, Gao Z, Yang B, Xin Z

OncoTargets and Therapy 2015, 8:3489-3497

Published Date: 24 November 2015

Polo-like kinase 2 acting as a promoter in human tumor cells with an abundance of TAp73

Hu ZB, Xu ZY, Liao XH, Yang X, Dong C, Luk K, Jin AM, Lu H

OncoTargets and Therapy 2015, 8:3475-3488

Published Date: 20 November 2015

Yttrium-90 radioembolization for advanced inoperable hepatocellular carcinoma

Lee VHF, Leung DKC, Luk MY, Tong CC, Law MWM, Ng SCY, Wong KK, Poon RTP, Kwong DLW, Leung TW

OncoTargets and Therapy 2015, 8:3457-3464

Published Date: 20 November 2015

High DEPTOR expression correlates with poor prognosis in patients with esophageal squamous cell carcinoma

Liu NB, Zhang JH, Liu YF, Li J, Zhang ZZ, Li JW, Liu WY, Huang C, Shen T, Gu CW, Gao DY, Wu X, Wu X

OncoTargets and Therapy 2015, 8:3449-3455

Published Date: 19 November 2015

Diagnostic value of SHOX2 DNA methylation in lung cancer: a meta-analysis

Zhao QT, Guo T, Wang HE, Zhang XP, Zhang H, Wang ZK, Yuan Z, Duan GC

OncoTargets and Therapy 2015, 8:3433-3439

Published Date: 19 November 2015

Profile of bevacizumab and its potential in the treatment of cervical cancer

Fisher CM, Schefter TE

OncoTargets and Therapy 2015, 8:3425-3431

Published Date: 19 November 2015

Baseline blood immunological profiling differentiates between Her2– breast cancer molecular subtypes: implications for immunomediated mechanisms of treatment response

Tudoran O, Virtic O, Balacescu L, Lisencu C, Fetica B, Gherman C, Balacescu O, Berindan-Neagoe I

OncoTargets and Therapy 2015, 8:3415-3423

Published Date: 18 November 2015

Novel prognostic genes of diffuse large B-cell lymphoma revealed by survival analysis of gene expression data

Li CL, Zhu B, Chen J, Huang XB

OncoTargets and Therapy 2015, 8:3407-3413

Published Date: 18 November 2015

Impact of lymphovascular invasion on recurrence and progression rates in patients with pT1 urothelial carcinoma of bladder after transurethral resection

Sha N, Xie L, Chen T, Xing C, Liu X, Zhang Y, Shen Z, Xu H, Wu Z, Hu H, Wu C

OncoTargets and Therapy 2015, 8:3401-3406

Published Date: 18 November 2015

Overexpression of miR-100 inhibits cell proliferation, migration, and chemosensitivity in human glioblastoma through FGFR3

Luan YX, Zhang SY, Zuo L, Zhou LX

OncoTargets and Therapy 2015, 8:3391-3400

Published Date: 17 November 2015

Experience with combination of nimotuzumab and intensity-modulated radiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma

Zhai RP, Ying HM, Kong FF, Du CR, Huang S, Zhou JJ, Hu CS

OncoTargets and Therapy 2015, 8:3383-3390

Published Date: 18 November 2015

Dynamin-related protein 1 is involved in micheliolide-induced breast cancer cell death

Jia Y, Zhou L, Tian C, Shi Y, Wang C, Tong Z

OncoTargets and Therapy 2015, 8:3371-3381

Published Date: 16 November 2015

Prognostic value of Bcl-2 expression in patients with non-small-cell lung cancer: a meta-analysis and systemic review

Zhang J, Wang SF, Wang L, Wang R, Chen SF, Pan B, Sun YH, Chen HQ

OncoTargets and Therapy 2015, 8:3361-3369

Published Date: 18 November 2015

Cetuximab could be more effective without prior bevacizumab treatment in metastatic colorectal cancer patients

Sato Y, Matsusaka S, Suenaga M, Shinozaki E, Mizunuma N

OncoTargets and Therapy 2015, 8:3329-3336

Published Date: 11 November 2015

Incidence and clinical significance of ESR1 mutations in heavily pretreated metastatic breast cancer patients

Niu J, Andres G, Kramer K, Kundranda MN, Alvarez RH, Klimant E, Parikh AR, Tan B, Staren ED, Markman M

OncoTargets and Therapy 2015, 8:3323-3328

Published Date: 11 November 2015

O-GlcNAcylation enhances the invasion of thyroid anaplastic cancer cells partially by PI3K/Akt1 pathway

Zhang P, Wang CL, Ma T, You SY

OncoTargets and Therapy 2015, 8:3305-3313

Published Date: 9 November 2015

Detection of epidermal growth factor receptor mutation in plasma as a biomarker in Chinese patients with early-stage non-small cell lung cancer

Guo K, Zhang ZP, Han L, Han J, Wang J, Zhou YA, Liu HG, Tong LP, Li XF, Yan XL

OncoTargets and Therapy 2015, 8:3289-3296

Published Date: 6 November 2015

The association between XRCC1 Arg399Gln polymorphism and risk of leukemia in different populations: a meta-analysis of case-control studies

Wang F, Zhao Q, He HR, Zhai YJ, Lu J, Hu HB, Zhou JS, Yang YH, Li YJ

OncoTargets and Therapy 2015, 8:3277-3287

Published Date: 6 November 2015

Use of taxane-containing induction chemotherapy in combination with concurrent chemoradiotherapy in Chinese patients with locally advanced nasopharyngeal carcinoma: a meta-analysis

Tian R, Ye HX, Zhang BG, Gu DY, Zhang BW, Teng ZP, Jin MY, Chen JF, Qi JW

OncoTargets and Therapy 2015, 8:3255-3263

Published Date: 5 November 2015

miR-21 inhibits the effects of cyclooxygenase-2 inhibitor NS398 on apoptosis and invasion in gastric cancer cells

Li HQ, Cheng J, Mao YQ, Jiang M, Fan XM

OncoTargets and Therapy 2015, 8:3245-3253

Published Date: 4 November 2015

Management experiences of primary angiosarcoma of breast: a retrospective study from single institute in the People’s Republic of China

Hu QC, Mei X, Feng Y, Ma JL, Yang ZZ, Shao ZM, Yu XL, Guo XM

OncoTargets and Therapy 2015, 8:3237-3243

Published Date: 4 November 2015

Implication of lncRNAs in pathogenesis of esophageal cancer

Tang WW, Wu QQ, Li SQ, Tong YS, Liu ZH, Yang TX, Xu Y, Cao XF

OncoTargets and Therapy 2015, 8:3219-3226

Published Date: 3 November 2015

miR-132 can inhibit glioma cells invasion and migration by target MMP16 in vitro

Wang HZ, Li XT, Wu C, Wu ZW, Li YY, Yang TQ, Chen GL, Xie XS, Huang YL, Du ZW, Zhou YX

OncoTargets and Therapy 2015, 8:3211-3218

Published Date: 3 November 2015

Correlation of C-X-C chemokine receptor 2 upregulation with poor prognosis and recurrence in human glioma

Yang L, Liu Z, Wu R, Yao Q, Gu Z, Liu M

OncoTargets and Therapy 2015, 8:3203-3209

Published Date: 2 November 2015

Combination of cetuximab and PP242 synergistically suppress the progression of wild-type KRAS colorectal carcinoma

Cheng L, Xia Z, Bian X, Li G, Hu J, Cao Y, Wang Q, Qian X

OncoTargets and Therapy 2015, 8:3185-3192

Published Date: 2 November 2015

miR-122 inhibits metastasis and epithelial–mesenchymal transition of non-small-cell lung cancer cells

Qin HF, Sha JP, Jiang CX, Gao XM, Qu LL, Yan HY, Xu TJ, Jiang QY, Gao HJ

OncoTargets and Therapy 2015, 8:3175-3184

Published Date: 29 October 2015

Treating patients with advanced rectal cancer and lateral pelvic lymph nodes with preoperative chemoradiotherapy based on pretreatment imaging

Otowa Y, Yamashita K, Kanemitsu K, Sumi Y, Yamamoto M, Kanaji S, Imanishi T, Nakamura T, Suzuki S, Tanaka K, Kakeji Y

OncoTargets and Therapy 2015, 8:3169-3173

Published Date: 29 October 2015

MicroRNA-328 enhances cellular motility through posttranscriptional regulation of PTPRJ in human hepatocellular carcinoma

Luo X, Yang S, Zhou C, Pan F, Li Q, Ma S

OncoTargets and Therapy 2015, 8:3159-3167

Published Date: 28 October 2015

A high LDL-C to HDL-C ratio predicts poor prognosis for initially metastatic colorectal cancer patients with elevations in LDL-C

Liao F, He W, Jiang C, Yin C, Guo G, Chen X, Qiu H, Rong Y, Zhang B, Xu D, Xia L

OncoTargets and Therapy 2015, 8:3135-3142

Published Date: 27 October 2015

SKF95365 induces apoptosis and cell-cycle arrest by disturbing oncogenic Ca2+ signaling in nasopharyngeal carcinoma cells

Zhang J, Wei J, He Q, Lin Y, Liang R, Ye J, Zhang Z, Li Y

OncoTargets and Therapy 2015, 8:3123-3133

Published Date: 27 October 2015

Serum dickkopf-1 as a biomarker in screening gastrointestinal cancers: a systematic review and meta-analysis

Liang B, Zhong L, He Q, Wang S, Pan Z, Wang T, Zhao Y

OncoTargets and Therapy 2015, 8:3115-3122

Published Date: 22 October 2015

Prognostic value of Notch-1 expression in hepatocellular carcinoma: a meta-analysis

Wu T, Jiao M, Jing L, Wang MC, Sun HF, Li Q, Bai YY, Wei YC, Nan KJ, Guo H

OncoTargets and Therapy 2015, 8:3105-3114

Published Date: 22 October 2015

Potential therapeutic strategy for gastric cancer peritoneal metastasis by NKG2D ligands-specific T cells

Liu XQ, Sun ML, Yu S, Liu K, Li XR, Shi H

OncoTargets and Therapy 2015, 8:3095-3104

Published Date: 22 October 2015

Transarterial oily chemoembolization with lidamycin shows potent therapeutic efficacy in VX2 rabbit liver tumor

Zhong G, Qi J, Huo S, Xue H, Xu Z, Li J, Zhou Y, Wu M, Li L

OncoTargets and Therapy 2015, 8:3079-3086

Published Date: 22 October 2015

A DNA vaccine encoding mutated HPV58 mE6E7-Fc-GPI fusion antigen and GM-CSF and B7.1

Wang H, Yu J, Li L

OncoTargets and Therapy 2015, 8:3067-3077

Published Date: 23 October 2015

Combined olaparib and oxaliplatin inhibits tumor proliferation and induces G2/M arrest and γ-H2AX foci formation in colorectal cancer

Xu K, Chen Z, Cui Y, Qin C, He Y, Song X

OncoTargets and Therapy 2015, 8:3047-3054

Published Date: 20 October 2015

Forkhead box protein A1 is a prognostic predictor and promotes tumor growth of gastric cancer

Ren H, Zhang P, Tang Y, Wu M, Zhang W

OncoTargets and Therapy 2015, 8:3029-3039

Published Date: 20 October 2015

miR-195 is a key regulator of Raf1 in thyroid cancer

Wang F, Jiang C, Sun Q, Yan F, Wang L, Fu Z, Liu T, Hu F

OncoTargets and Therapy 2015, 8:3021-3028

Published Date: 20 October 2015

EGFR gene-mutation status correlated with therapeutic decision making in lung adenocarcinoma

Ren YY, Yao YB, Ma Q, Zhong DS

OncoTargets and Therapy 2015, 8:3017-3020

Published Date: 20 October 2015

SOX2 expression is associated with FGFR fusion genes and predicts favorable outcome in lung squamous cell carcinomas

Zheng S, Pan Y, Wang R, Li Y, Cheng C, Shen X, Li B, Zheng D, Sun Y, Chen H

OncoTargets and Therapy 2015, 8:3009-3016

Published Date: 19 October 2015

MicroRNA-766 targeting regulation of SOX6 expression promoted cell proliferation of human colorectal cancer

Li YC, Li CF, Chen LB, Li DD, Yang L, Jin JP, Zhang B

OncoTargets and Therapy 2015, 8:2981-2988

Published Date: 20 October 2015

Links between cancer stem cells and epithelial– mesenchymal transition

Wang SS, Jiang J, Liang XH, Tang YL

OncoTargets and Therapy 2015, 8:2973-2980

Published Date: 16 October 2015

Mutation analysis underlying the downregulation of the thyroid hormone receptor β1 gene in the Chinese breast cancer population

Ling YQ, Ling XL, Fan L, Wang Y, Li Q

OncoTargets and Therapy 2015, 8:2967-2972

Published Date: 16 October 2015

Differential regulation of human Eag1 channel expression by serum and epidermal growth factor in lung and breast cancer cells

Acuña-Macías I, Vera E, Vázquez-Sánchez AY, Mendoza-Garrido ME, Camacho J

OncoTargets and Therapy 2015, 8:2959-2965

Published Date: 16 October 2015

Molecular profiling in the treatment of colorectal cancer: focus on regorafenib

Yan Y, Grothey A

OncoTargets and Therapy 2015, 8:2949-2957

Published Date: 15 October 2015

A human leucyl-tRNA synthetase as an anticancer target

Gao G, Yao Y, Li K, Mashausi DS, Li D, Negi H, Kamle S, Chen H, Wu Z, Zhou H, Li D

OncoTargets and Therapy 2015, 8:2933-2942

Published Date: 15 October 2015

Deregulation of secreted frizzled-related proteins is associated with aberrant β-catenin activation in the carcinogenesis of oral submucous fibrosis

Zhou S, Chen L, Mashrah M, Zhu Y, Liu J, Yang X, He Z, Wang L, Xiang T, Yao Z, Guo F, Yang W, Zhang C

OncoTargets and Therapy 2015, 8:2923-2931

Published Date: 14 October 2015

EGFR-TKIs in adjuvant treatment of lung cancer: to give or not to give?

Milovancev A, Stojsic V, Zaric B, Kovacevic T, Sarcev T, Perin B, Zarogoulidis K, Tsirgogianni K, Freitag L, Darwiche K, Tsavlis D, Zissimopoulos A, Stratakos G, Zarogoulidis P

OncoTargets and Therapy 2015, 8:2915-2921

Published Date: 13 October 2015

Genetic polymorphisms of CYP1A1 and risk of leukemia: a meta-analysis

Lu J, Zhao Q, Zhai YJ, He HR, Yang LH, Gao F, Zhou RS, Zheng J, Ma XC

OncoTargets and Therapy 2015, 8:2883-2902

Published Date: 12 October 2015

Study of internal mammary sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy

Cao XS, Cong BB, Sun X, Qiu PF, Wang YS

OncoTargets and Therapy 2015, 8:2873-2874

Published Date: 9 October 2015

Changing attitudes toward needle biopsies of breast cancer in Shanghai: experience and current status over the past 8 years

Hao S, Liu ZB, Ling H, Chen JJ, Shen JP, Yang WT, Shao ZM

OncoTargets and Therapy 2015, 8:2865-2871

Published Date: 9 October 2015

Role of estrogen in lung cancer based on the estrogen receptor-epithelial mesenchymal transduction signaling pathways

Zhao XZ, Liu Y, Zhou LJ, Wang ZQ, Wu ZH, Yang XY

OncoTargets and Therapy 2015, 8:2849-2863

Published Date: 9 October 2015

Postoperative intensity-modulated radiation therapy provides favorable local control and low toxicities in patients with soft tissue sarcomas in the extremities and trunk wall

Wang JY, Wang SL, Song YW, Liu XF, Jin J, Wang WH, Yu ZH, Liu YP, Li YX

OncoTargets and Therapy 2015, 8:2843-2847

Published Date: 9 October 2015

CXCL12 genetic variants as prognostic markers in nasopharyngeal carcinoma

Chen RW, Xu YF, Du XJ, Liu N, Li YQ, He QM, Tang LL, Mao YP, Sun Y, Chen L, Ma J

OncoTargets and Therapy 2015, 8:2835-2842

Published Date: 8 October 2015

Does night-shift work increase the risk of prostate cancer? a systematic review and meta-analysis

Rao D, Yu H, Bai Y, Zheng X, Xie L

OncoTargets and Therapy 2015, 8:2817-2826

Published Date: 5 October 2015

Molecular diagnostics of a single drug-resistant multiple myeloma case using targeted next-generation sequencing

Ikeda H, Ishiguro K, Igarashi T, Aoki Y, Hayashi T, Ishida T, Sasaki Y, Tokino T, Shinomura Y

OncoTargets and Therapy 2015, 8:2805-2815

Published Date: 5 October 2015

Association between the COMT Val158Met polymorphism and risk of cancer: evidence from 99 case–control studies

Zhou Q, Wang Y, Chen AH, Tao YL, Song HM, Li W, Tao J, Zuo MZ

OncoTargets and Therapy 2015, 8:2791-2803

Published Date: 5 October 2015

Spotlight on decitabine for myelodysplastic syndromes in Chinese patients

Jing Y, Shen X, Mei Q, Han W

OncoTargets and Therapy 2015, 8:2783-2790

Published Date: 3 October 2015

Angiogenesis inhibitors rechallenge in patients with advanced non-small-cell lung cancer: a pooled analysis of randomized controlled trials

Zhao LD, Li W, Zhang HY, Hou N, Guo LW, Gao QL

OncoTargets and Therapy 2015, 8:2775-2781

Published Date: 3 October 2015

ESHAP chemotherapy is efficient in refractory/relapsed primary central nervous system lymphoma: report of four cases

Ungur R, Tempescul A, Berthou C, Bagacean C, Radeanu D, Muresan A, Zdrenghea M

OncoTargets and Therapy 2015, 8:2771-2773

Published Date: 1 October 2015

Increased risk of developing lung cancer in Asian patients carrying the TERT rs2736098 G>A polymorphism: evidence from 3,354 cases and 3,518 controls

Yang ZH, Zhang XL, Fang SR, Tan Y, Yan HJ, Gu W, Wang JH

OncoTargets and Therapy 2015, 8:2757-2765

Published Date: 30 September 2015

Anti-DR5 mAb inhibits proliferation of human fibroblast-like synovial cells and reduces their cytokine secretion in vitro

Zhang M, Shi C, Xia C, Yang J, Niu X, Zhuang G, Yin P

OncoTargets and Therapy 2015, 8:2745-2755

Published Date: 29 September 2015

Prognostic role of neutrophil to lymphocyte ratio in lung cancers: a meta-analysis including 7,054 patients

Zhao QT, Yang Y, Xu S, Zhang XP, Wang HE, Zhang H, Wang ZK, Yuan Z, Duan GC

OncoTargets and Therapy 2015, 8:2731-2738

Published Date: 29 September 2015

Comparative study on individual aromatase inhibitors on cardiovascular safety profile: a network meta-analysis

Zhao XH, Liu L, Li K, Li WS, Zhao L, Zou HW

OncoTargets and Therapy 2015, 8:2721-2730

Published Date: 29 September 2015

The predictive effect of overexpressed miR-34a on good survival of cancer patients: a systematic review and meta-analysis

Wang J, Dan GR, Zhao JQ, Ding Y, Ye F, Sun HQ, Jiang F, Cheng J, Yuan FH, Zou ZM

OncoTargets and Therapy 2015, 8:2709-2719

Published Date: 25 September 2015

Validation study of the modified injection technique for internal mammary sentinel lymph node biopsy in breast cancer

Cong BB, Cao XS, Qiu PF, Liu YB, Zhao T, Chen P, Wang CJ, Zhang ZP, Sun X, Wang YS

OncoTargets and Therapy 2015, 8:2705-2708

Published Date: 24 September 2015

A study on the effect of IL-6 gene polymorphism on the prognosis of non-small-cell lung cancer

Jia W, Fei GH, Hu JG, Hu XW

OncoTargets and Therapy 2015, 8:2699-2704

Published Date: 23 September 2015

miR-98 targets ITGB3 to inhibit proliferation, migration, and invasion of non-small-cell lung cancer

Ni R, Huang Y, Wang J

OncoTargets and Therapy 2015, 8:2689-2697

Published Date: 22 September 2015

Associations of polymorphisms in NAT2 gene with risk and metastasis of osteosarcoma in young Chinese population

Huang Z, Yuan L, Jiang Z, Wang D

OncoTargets and Therapy 2015, 8:2675-2680

Published Date: 22 September 2015

Long noncoding RNA CCAT2 promotes breast tumor growth by regulating the Wnt signaling pathway

Cai Y, He J, Zhang D

OncoTargets and Therapy 2015, 8:2657-2664

Published Date: 21 September 2015

Diarrhea as initial manifestation of pulmonary artery intimal sarcoma: a case report and literature review

Xu X, Zhang R, Hu H, Ye W, Wang J, Chen L, Qiu L, Ying K

OncoTargets and Therapy 2015, 8:2651-2656

Published Date: 18 September 2015

Combination of Bcl-2 and MYC protein expression improves high-risk stratification in diffuse large B-cell lymphoma

Wang J, Zhou M, Xu JY, Chen B, Ouyang J

OncoTargets and Therapy 2015, 8:2645-2650

Published Date: 18 September 2015

miR-205 suppresses the proliferative and migratory capacity of human osteosarcoma MG-63 cells by targeting VEGFA

Wang L, Shan M, Yang F, Liu Y, Qi H, Zhou L, Qiu L, Li Y

OncoTargets and Therapy 2015, 8:2635-2642

Published Date: 16 September 2015

Role of DFNA5 in hearing loss and cancer – a comment on Rakusic et al

Croes L, Op de Beeck K, Van Camp G

OncoTargets and Therapy 2015, 8:2613-2615

Published Date: 15 September 2015

Liposomal curcumin inhibits hypoxia-induced angiogenesis after transcatheter arterial embolization in VX2 rabbit liver tumors

Dai F, Zhang XM, Shen WR, Chen J, Liu LC, Gao GJ

OncoTargets and Therapy 2015, 8:2601-2611

Published Date: 15 September 2015

Increased serum levels of interleukin-10 predict poor prognosis in extranodal natural killer/T-cell lymphoma patients receiving asparaginase-based chemotherapy

Wang H, Wang L, Wuxiao ZJ, Huang HQ, Jiang WQ, Li ZM, Lu Y, Xia ZJ

OncoTargets and Therapy 2015, 8:2589-2599

Published Date: 14 September 2015

Protein tyrosine phosphatase SHP-1 sensitizes EGFR/HER-2 positive breast cancer cells to trastuzumab through modulating phosphorylation of EGFR and HER-2

Wu YF, Li R, Zhang JY, Wang G, Liu B, Huang XF, Zhang T, Luo RC

OncoTargets and Therapy 2015, 8:2577-2587

Published Date: 14 September 2015

Prognostic role of LSD1 in various cancers: evidence from a meta-analysis

Wu J, Hu LX, Du YY, Kong FL, Pan YY

OncoTargets and Therapy 2015, 8:2565-2570

Published Date: 15 September 2015

The engineered Salmonella typhimurium inhibits tumorigenesis in advanced glioma

Chen JQ, Zhan YF, Wang W, Jiang SN, Li XY

OncoTargets and Therapy 2015, 8:2555-2563

Published Date: 15 September 2015

New developments in the management of advanced melanoma – role of pembrolizumab

Improta G, Leone I, Donia M, Gieri S, Pelosi G, Fraggetta F

OncoTargets and Therapy 2015, 8:2535-2543

Published Date: 14 September 2015

The clinical analysis of acute pancreatitis in colorectal cancer patients undergoing chemotherapy after operation

Ji YL, Han Z, Shao LM, Li YL, Zhao L, Zhao YH

OncoTargets and Therapy 2015, 8:2527-2533

Published Date: 11 September 2015

The expression and clinical significance of HDGF in osteosarcoma

Chen Z, Qiu S, Lu X

OncoTargets and Therapy 2015, 8:2509-2517

Published Date: 9 September 2015

Treatment and survival analyses of completely resected thymic carcinoma patients

Mao Y, Wu S

OncoTargets and Therapy 2015, 8:2503-2507

Published Date: 9 September 2015

Association between the polymorphisms of urokinase plasminogen activation system and cancer risk: a meta-analysis

Xu Z, Meng LL, Lin JZ, Ling Y, Chen SX, Lin N

OncoTargets and Therapy 2015, 8:2493-2502

Published Date: 9 September 2015

Thyroid transcription factor-1 expression is significantly associated with mutations in exon 21 of the epidermal growth factor receptor gene in Chinese patients with lung adenocarcinoma

Zhao QC, Xu S, Liu JH, Li Y, Fan YG, Shi T, Wei S, Tang SC, Liu HY, Chen J

OncoTargets and Therapy 2015, 8:2469-2478

Published Date: 7 September 2015

No associations between aromatase gene polymorphisms and breast cancer risk in Saudi patients

Alanazi M, Alabdulkarim HA, Shaik JP, Al Naeem A, Elrobh M, Al Amri A, al-Mukaynizi FB, Semlali A, Warsy A, Parine NR

OncoTargets and Therapy 2015, 8:2453-2459

Published Date: 3 September 2015

A common genetic variation in CEBPE and acute lymphoblastic leukemia: a meta-analysis of the available evidence

Zhang XX, Du YF, Zhai YJ, Gao F, Yang YJ, Ma XC, Lu J, Zheng J

OncoTargets and Therapy 2015, 8:2443-2451

Published Date: 7 September 2015

Treatment compliance and severe adverse events limit the use of tyrosine kinase inhibitors in refractory thyroid cancer

Chrisoulidou A, Mandanas S, Margaritidou E, Mathiopoulou L, Boudina M, Georgopoulos K, Pazaitou-Panayiotou K

OncoTargets and Therapy 2015, 8:2435-2442

Published Date: 3 September 2015

The expression of the PI3K/AKT/mTOR pathway in gastric cancer and its role in gastric cancer prognosis

Ying J, Xu Q, Liu B, Zhang G, Chen L, Pan H

OncoTargets and Therapy 2015, 8:2427-2433

Published Date: 1 September 2015

Dietary fiber, whole grains, carbohydrate, glycemic index, and glycemic load in relation to risk of prostate cancer

Wang RJ, Tang JE, Chen Y, Gao JG

OncoTargets and Therapy 2015, 8:2415-2426

Published Date: 2 September 2015

Bevacizumab plus chemotherapy as third- or later-line therapy in patients with heavily treated metastatic colorectal cancer

Yang Q, Yin CX, Liao FX, Huang YY, He WZ, Jiang C, Guo GF, Zhang B, Xia LP

OncoTargets and Therapy 2015, 8:2407-2413

Published Date: 1 September 2015

The distinctive nature of adenocarcinoma of the lung

Roviello G

OncoTargets and Therapy 2015, 8:2399-2406

Published Date: 2 September 2015

Chronic neutrophilic leukemia: a clinical perspective

Menezes J, Cigudosa JC

OncoTargets and Therapy 2015, 8:2383-2390

Published Date: 1 September 2015

The impact of histological types on the efficacy of angiogenesis inhibitors in the treatment of advanced NSCLC: a meta-analysis of randomized controlled trials

Zhang J, Liu J, Chen HG, Wu WB, Li XJ, Wu YH, Zhang K, Gu LJ

OncoTargets and Therapy 2015, 8:2375-2382

Published Date: 31 August 2015

Apoptotic effect of cordycepin combined with cisplatin and/or paclitaxel on MA-10 mouse Leydig tumor cells

Kang FC, Chen PJ, Pan BS, Lai MS, Chen YC, Huang BM

OncoTargets and Therapy 2015, 8:2345-2360

Published Date: 1 September 2015

The prognosis factor of adjuvant radiation therapy after surgery in uterine sarcomas

Hou HL, Meng MB, Chen XL, Zhao LJ, Zhu L, Zhang BL, Wang P

OncoTargets and Therapy 2015, 8:2339-2344

Published Date: 28 August 2015

Clinical and prognostic significance of pathological and inflammatory markers in the surgical treatment of locally advanced colorectal cancer

Sokolov M, Angelov K, Vasileva M, Atanasova MP, Vlahova A, Todorov G

OncoTargets and Therapy 2015, 8:2329-2337

Published Date: 1 September 2015

Micheliolide overcomes KLF4-mediated cisplatin resistance in breast cancer cells by downregulating glutathione

Jia Y, Zhang C, Zhou L, Xu H, Shi Y, Tong Z

OncoTargets and Therapy 2015, 8:2319-2327

Published Date: 28 August 2015

Genetic polymorphisms of PAI-1 and PAR-1 are associated with acute normal tissue toxicity in Chinese rectal cancer patients treated with pelvic radiotherapy

Zhang H, Wang M, Shi T, Shen L, Zhu J, Sun M, Deng Y, Liang L, Li G, Wu Y, Fan M, Wei Q, Zhang Z

OncoTargets and Therapy 2015, 8:2291-2301

Published Date: 27 August 2015

Effects of magnetic nanoparticles of Fe3O4 combinated with gambogic acid on apoptosis of SMMC-7721 cells

Tian L, Chen BA, Cheng J, Guo QL

OncoTargets and Therapy 2015, 8:2285-2290

Published Date: 26 August 2015

Prognostic value of FDG PET/CT in head and neck squamous cell carcinomas

Dequanter D, Shahla M, Aubert C, Deniz Y, Lothaire P

OncoTargets and Therapy 2015, 8:2279-2283

Published Date: 26 August 2015

Expression profiles of pivotal microRNAs and targets in thyroid papillary carcinoma: an analysis of The Cancer Genome Atlas

Cong D, He MZ, Chen SL, Liu XL, Liu XD, Sun H

OncoTargets and Therapy 2015, 8:2271-2277

Published Date: 26 August 2015

Cemented allograft-prosthesis composite reconstruction for the proximal femur tumor

Min L, Tang F, Duan H, Zhou Y, Zhang WL, Shi R, Tu CQ

OncoTargets and Therapy 2015, 8:2261-2269

Published Date: 25 August 2015

Trametinib: a MEK inhibitor for management of metastatic melanoma

Lugowska I, Koseła-Paterczyk H, Kozak K, Rutkowski P

OncoTargets and Therapy 2015, 8:2251-2259

Published Date: 25 August 2015

Expressions and clinical significance of autophagy-related markers Beclin1, LC3, and EGFR in human cervical squamous cell carcinoma

Hu YF, Lei X, Zhang HY, Ma JW, Yang WW, Chen ML, Cui J, Zhao H

OncoTargets and Therapy 2015, 8:2243-2249

Published Date: 24 August 2015

Comparing two assays for clinical genomic profiling: the devil is in the data

Squillace RM, Frampton GM, Stephens PJ, Ross JS, Miller VA

OncoTargets and Therapy 2015, 8:2237-2242

Published Date: 24 August 2015

MicroRNA-212 inhibits hepatocellular carcinoma cell proliferation and induces apoptosis by targeting FOXA1

Tu H, Wei G, Cai Q, Chen X, Sun Z, Cheng C, Zhang L, Feng Y, Zhou H, Zhou B, Zeng T

OncoTargets and Therapy 2015, 8:2227-2235

Published Date: 24 August 2015

Retrospective study of irinotecan/cisplatin followed by etoposide/cisplatin or the reverse sequence in extensive-stage small cell lung cancer

Xiao XG, Wang SJ, Xia S, Zou M, Li Y, Wei Y, Mei Q, Chen Y

OncoTargets and Therapy 2015, 8:2209-2214

Published Date: 21 August 2015

Disruption of NF-κB signaling by fluoxetine attenuates MGMT expression in glioma cells

Song T, Li H, Tian Z, Xu C, Liu J, Guo Y

OncoTargets and Therapy 2015, 8:2199-2208

Published Date: 20 August 2015

Epothilones in epithelial ovarian, fallopian tube, or primary peritoneal cancer: a systematic review

Zagouri F, Sergentanis TN, Chrysikos D, Dimopoulos MA, Bamias A

OncoTargets and Therapy 2015, 8:2187-2198

Published Date: 20 August 2015

The association between miR-499 polymorphism and cancer susceptibility: a meta-analysis

Xu Z, Zhang E, Duan W, Sun C, Bai S, Tan X

OncoTargets and Therapy 2015, 8:2179-2186

Published Date: 20 August 2015

Morphologic patterns and imaging features of intracranial hemangiopericytomas: a retrospective analysis

Pang HP, Yao ZW, Ren Y, Liu GB, Zhang JW, Feng XY

OncoTargets and Therapy 2015, 8:2169-2178

Published Date: 20 August 2015

Current and emerging treatment options for hairy cell leukemia

López-Rubio M, Garcia-Marco JA

OncoTargets and Therapy 2015, 8:2147-2156

Published Date: 19 August 2015

Clinical efficacy of percutaneous vertebroplasty combined with intensity-modulated radiotherapy for spinal metastases in patients with NSCLC

Li Y, Qing Y, Zhang ZM, Li MX, Xie JY, Wang G, Wang D

OncoTargets and Therapy 2015, 8:2139-2145

Published Date: 19 August 2015

Alteration of ASIC1 expression in clear cell renal cell carcinoma

Li Y, Xu G, Huang K, Wang J, Zhang J, Liu J, Wang Z, Chen G

OncoTargets and Therapy 2015, 8:2121-2127

Published Date: 14 August 2015

CAG repeat polymorphisms in the androgen receptor and breast cancer risk in women: a meta-analysis of 17 studies

Mao Q, Qiu M, Dong G, Xia W, Zhang S, Xu Y, Wang J, Rong Y, Xu L, Jiang F

OncoTargets and Therapy 2015, 8:2111-2120

Published Date: 13 August 2015

Hepatoma-derived growth factor predicts unfavorable prognosis of epithelial ovarian cancer

Liu XJ, Liu WL, Yang FM, Yang XQ, Lu XF

OncoTargets and Therapy 2015, 8:2101-2109

Published Date: 13 August 2015

Urine microRNAs as biomarkers for bladder cancer: a diagnostic meta-analysis

Cheng Y, Deng X, Yang X, Li P, Zhang X, Li P, Tao J, Lu Q, Wang Z

OncoTargets and Therapy 2015, 8:2089-2096

Published Date: 11 August 2015

Heme oxygenase-1 is a predictive biomarker for therapeutic targeting of advanced clear cell renal cell carcinoma treated with sorafenib or sunitinib

Zheng WX, Yan F, Xue Q, Wu GJ, Qin WJ, Wang FL, Qin J, Tian CJ, Yuan JL

OncoTargets and Therapy 2015, 8:2081-2088

Published Date: 10 August 2015

PP4R1 accelerates cell growth and proliferation in HepG2 hepatocellular carcinoma

Wu G, Ma ZY, Qian JM, Liu B

OncoTargets and Therapy 2015, 8:2067-2074

Published Date: 7 August 2015

Phytochemicals modulate carcinogenic signaling pathways in breast and hormone-related cancers

Cojocneanu Petric R, Braicu C, Raduly L, Zanoaga O, Dragos N, Monroig P, Dumitrascu D, Berindan-Neagoe I

OncoTargets and Therapy 2015, 8:2053-2066

Published Date: 6 August 2015

Nivolumab in the treatment of malignant melanoma: review of the literature

Mashima E, Inoue A, Sakuragi Y, Yamaguchi T, Sasaki N, Hara Y, Omoto D, Ohmori S, Haruyama S, Sawada Y, Yoshioka M, Nishio D, Nakamura M

OncoTargets and Therapy 2015, 8:2045-2051

Published Date: 6 August 2015

Meta-analysis of postoperative adjuvant chemotherapy without radiotherapy in early stage non-small cell lung cancer

Chen YY, Wang LW, Wang SY, Wu BB, Wang ZM, Chen FF, Xiong B

OncoTargets and Therapy 2015, 8:2033-2043

Published Date: 4 August 2015

Computer-aided classification of lung nodules on computed tomography images via deep learning technique

Hua KL, Hsu CH, Hidayati SC, Cheng WH, Chen YJ

OncoTargets and Therapy 2015, 8:2015-2022

Published Date: 4 August 2015

Inactivity of imatinib in gastrointestinal stromal tumors (GISTs) harboring a KIT activation-loop domain mutation (exon 17 mutation pN822K)

Spitaleri G, Biffi R, Barberis M, Fumagalli C, Toffalorio F, Catania C, Noberasco C, Lazzari C, de Marinis F, De Pas T

OncoTargets and Therapy 2015, 8:1997-2003

Published Date: 18 August 2015

The histone demethylase PHF8 promotes prostate cancer cell growth by activating the oncomiR miR-125b

Ma Q, Chen Z, Jia G, Lu X, Xie X, Jin W

OncoTargets and Therapy 2015, 8:1979-1988

Published Date: 10 August 2015

Low claudin-6 expression correlates with poor prognosis in patients with non-small cell lung cancer

Wang Q, Zhang Y, Zhang T, Han ZG, Shan L

OncoTargets and Therapy 2015, 8:1971-1977

Published Date: 31 July 2015

The role of 18F-FDG PET/CT imaging in patient with malignant PEComa treated with mTOR inhibitor

Sun L, Sun XR, Li YH, Xing LG

OncoTargets and Therapy 2015, 8:1967-1970

Published Date: 30 July 2015

−148 C/T polymorphism of Axin2 contributes to a decreased risk of cancer: evidence from a meta-analysis

Zhong AY, Pan X, Shi MH, Xu HJ

OncoTargets and Therapy 2015, 8:1957-1966

Published Date: 29 July 2015

Prognostic value of IGF-1R expression in bone and soft tissue sarcomas: a meta-analysis

Liang JB, Li BH, Yuan L, Ye ZM

OncoTargets and Therapy 2015, 8:1949-1955

Published Date: 29 July 2015

Hypoxia-inducible factor-1α induces multidrug resistance protein in colon cancer

Lv Y, Zhao S, Han J, Zheng L, Yang Z, Zhao L

OncoTargets and Therapy 2015, 8:1941-1948

Published Date: 29 July 2015

Determination and validation of mTOR kinase-domain 3D structure by homology modeling

Lakhlili W, Chevé G, Yasri A, Ibrahimi A

OncoTargets and Therapy 2015, 8:1923-1930

Published Date: 30 July 2015

Whole blood defensin mRNA expression is a predictive biomarker of docetaxel response in castration-resistant prostate cancer

Kohli M, Young CYF, Tindall DJ, Nandy D, McKenzie KM, Bevan GH, Donkena KV

OncoTargets and Therapy 2015, 8:1915-1922

Published Date: 30 July 2015

Malignant glomus tumor of the lung with multiorgan metastases: case report and literature review

Dong LL, Chen EG, Sheikh IS, Jiang ZN, Huang AH, Ying KJ

OncoTargets and Therapy 2015, 8:1909-1914

Published Date: 28 July 2015

Peritumoral SPARC expression and patient outcome with resectable intrahepatic cholangiocarcinoma

Cheng CT, Chu YY, Yeh CN, Huang SC, Chen MH, Wang SY, Tsai CY, Chiang KC, Chen YY, Ma MC, Liu CT, Chen TW, Yeh TS

OncoTargets and Therapy 2015, 8:1899-1907

Published Date: 28 July 2015

The expression and significance of Gal-3 and MUC1 in colorectal cancer and colon cancer

Wang H, Wang L

OncoTargets and Therapy 2015, 8:1893-1898

Published Date: 27 July 2015

Is there any association between hormonal contraceptives and cervical neoplasia in a poor Nigerian setting?

Ajah LO, Chigbu CO, Ozumba BC, Oguanuo TC, Ezeonu PO

OncoTargets and Therapy 2015, 8:1887-1892

Published Date: 27 July 2015

Investigation of brain tumors using 18F-fluorobutyl ethacrynic amide and its metabolite with positron emission tomography

Huang YC, Huang HL, Yeh CN, Lin KJ, Yu CS

OncoTargets and Therapy 2015, 8:1877-1885

Published Date: 24 July 2015

miR-20b overexpression is predictive of poor prognosis in gastric cancer

Xue TM, Tao LD, Zhang M, Xu GC, Zhang J, Zhang PJ

OncoTargets and Therapy 2015, 8:1871-1876

Published Date: 24 July 2015

p27Kip1 and Ser10-phosphorylated p27Kip1 in breast cancer: clinical significance and expression

Song W, Xie RL, Zhu AY, Xu YM, Shi YQ, Shen Y, Zhang WW, Yang F, Guan XX

OncoTargets and Therapy 2015, 8:1863-1869

Published Date: 24 July 2015

Ganetespib: research and clinical development

Jhaveri K, Modi S

OncoTargets and Therapy 2015, 8:1849-1858

Published Date: 24 July 2015

Expression of ARs in triple negative breast cancer tumors: a potential prognostic factor?

Giannos A, Filipits M, Zagouri F, Brandstetter A, Tsigginou A, Sotiropoulou M, Papaspyrou I, Sergentanis TN, Psaltopoulou T, Rodolakis A, Antsaklis A, Dimopoulos MA, Dimitrakakis C

OncoTargets and Therapy 2015, 8:1843-1847

Published Date: 23 July 2015

Association between GSTP1 polymorphisms and prognosis of osteosarcoma in patients treated with chemotherapy: a meta-analysis

Pu FF, Chen FX, Chen SF, Wang BC, Liu JX, Shao ZW

OncoTargets and Therapy 2015, 8:1835-1842

Published Date: 23 July 2015

Follicular dendritic cell sarcoma: two rare cases and a brief review of the literature

Ma Y, Sun JJ, Yang CC, Yuan DD, Liu J

OncoTargets and Therapy 2015, 8:1823-1830

Published Date: 24 July 2015

Diffuse anterior retinoblastoma: current concepts

Yang J, Dang Y, Zhu Y, Zhang C

OncoTargets and Therapy 2015, 8:1815-1821

Published Date: 22 July 2015

Upregulation of nucleostemin in colorectal cancer and its effects on cell malignancy

Wei B, Huang Q, Zhong X

OncoTargets and Therapy 2015, 8:1805-1814

Published Date: 21 July 2015

MTA1 promotes proliferation and invasion in human gastric cancer cells

Yao Y, Feng S, Xiao M, Li Y, Yang L, Gong J

OncoTargets and Therapy 2015, 8:1785-1794

Published Date: 20 July 2015

miR-32 functions as a tumor suppressor and directly targets SOX9 in human non-small cell lung cancer

Zhu D, Chen H, Yang X, Chen W, Wang L, Xu J, Yu L

OncoTargets and Therapy 2015, 8:1773-1783

Published Date: 20 July 2015

Volasertib for AML: clinical use and patient consideration

Hao Z, Kota V

OncoTargets and Therapy 2015, 8:1761-1771

Published Date: 17 July 2015

IL-2 -330T/G polymorphism and cancer risk: a meta-analysis

Zhao HY, Wang R

OncoTargets and Therapy 2015, 8:1753-1760

Published Date: 17 July 2015

Single nucleotide polymorphisms of microRNA processing genes and outcome of non-Hodgkin’s lymphoma

Gao Y, Diao L, Li H, Guo Z

OncoTargets and Therapy 2015, 8:1735-1741

Published Date: 15 July 2015

B7-H3 silencing by RNAi inhibits tumor progression and enhances chemosensitivity in U937 cells

Zhang W, Wang J, Wang Y, Dong F, Zhu M, Wan W, Li H, Wu F, Yan X, Ke X

OncoTargets and Therapy 2015, 8:1721-1733

Published Date: 14 July 2015

A tale of the two PEGylated liposomal doxorubicins

Chou HH, Lin H, Liu JM

OncoTargets and Therapy 2015, 8:1719-1720

Published Date: 13 July 2015

The prognostic significance of protein tyrosine phosphatase 4A2 in breast cancer

Zhao D, Guo L, Neves H, Yuen HF, Zhang SD, McCrudden CM, Wen Q, Zhang J, Zeng Q, Kwok HF, Lin Y

OncoTargets and Therapy 2015, 8:1707-1717

Published Date: 13 July 2015

Significance of downregulation of renal organic cation transporter (SLC47A1) in cisplatin-induced proximal tubular injury

Mizuno T, Sato W, Ishikawa K, Terao Y, Takahashi K, Noda Y, Yuzawa Y, Nagamatsu T

OncoTargets and Therapy 2015, 8:1701-1706

Published Date: 10 July 2015

Screening of potential diagnostic markers and therapeutic targets against colorectal cancer

Tian XQ, Sun DF, Zhao SL, Xiong H, Fang JY

OncoTargets and Therapy 2015, 8:1691-1699

Published Date: 8 July 2015

AKT2-knockdown suppressed viability with enhanced apoptosis, and attenuated chemoresistance to temozolomide of human glioblastoma cells in vitro and in vivo

Cui Y, Lin J, Zuo JL, Zhang L, Dong Y, Hu GH, Luo C, Chen JX, Lu YC

OncoTargets and Therapy 2015, 8:1681-1690

Published Date: 8 July 2015

Association between EHBP1 rs721048(A>G) polymorphism and prostate cancer susceptibility: a meta-analysis of 17 studies involving 150,678 subjects

Ao X, Liu Y, Bai XY, Qu X, Xu Z, Hu G, Chen M, Wu H

OncoTargets and Therapy 2015, 8:1671-1680

Published Date: 7 July 2015

FH535 inhibited metastasis and growth of pancreatic cancer cells

Wu MY, Liang RR, Chen K, Shen M, Tian YL, Li DM, Duan WM, Gui Q, Gong FR, Lian L, Li W, Tao M

OncoTargets and Therapy 2015, 8:1651-1670

Published Date: 6 July 2015

High expression of UBD correlates with epirubicin resistance and indicates poor prognosis in triple-negative breast cancer

Tao H, Liu Z, Li H, Xie W, Zhang R, Zhu L, Guo F, Han Y, Sheng Y, Xie X

OncoTargets and Therapy 2015, 8:1643-1649

Published Date: 6 July 2015

Mixed acinar-endocrine carcinoma of pancreas: a case report and brief review of the literature

Liu Z, Dong C, Wang C, Liu Q, Sun D, Wang L

OncoTargets and Therapy 2015, 8:1633-1642

Published Date: 3 July 2015

Microwave ablation: state-of-the-art review

Hernández JI, Cepeda MFJ, Valdés F, Guerrero GD

OncoTargets and Therapy 2015, 8:1627-1632

Published Date: 6 July 2015

Expression of MMP-1/PAR-1 and patterns of invasion in oral squamous cell carcinoma as potential prognostic markers

Fan HX, Chen Y, Ni BX, Wang S, Sun M, Chen D, Zheng JH

OncoTargets and Therapy 2015, 8:1619-1626

Published Date: 3 July 2015

Rapidly progressive stage IVB mycosis fungoides treated with low-dose total skin electron beam therapy

Chowdhary M, Kabbani AA, Rimtepathip P, Cole Jr DA, Cohen DJ

OncoTargets and Therapy 2015, 8:1597-1601

Published Date: 1 July 2015

Clinicopathological significance of fascin-1 expression in patients with non-small cell lung cancer

Ling XL, Zhang T, Hou XM, Zhao D

OncoTargets and Therapy 2015, 8:1589-1595

Published Date: 30 June 2015

Prognostic analysis of Chinese patients with metastasis renal cell cancer receiving sorafenib: results from a multicenter long-term follow-up retrospective study

Guo F, Han T, Liu Z, Song X, Zhang Q, Kong X, Li C, Li Z, Li C, Qu S, Zheng Z, Piao Y, Han Y, Xie X

OncoTargets and Therapy 2015, 8:1581-1588

Published Date: 26 June 2015

Profile of blinatumomab and its potential in the treatment of relapsed/refractory acute lymphoblastic leukemia

Ribera JM, Ferrer A, Ribera J, Genescà E

OncoTargets and Therapy 2015, 8:1567-1574

Published Date: 24 June 2015

Role of integrin-linked kinase in drug resistance of lung cancer

Jia Z

OncoTargets and Therapy 2015, 8:1561-1565

Published Date: 23 June 2015

Enhanced NK cell adoptive antitumor effects against breast cancer in vitro via blockade of the transforming growth factor-β signaling pathway

Zhao Y, Hu JY, Li RG, Song J, Kang YJ, Liu S, Zhang DW

OncoTargets and Therapy 2015, 8:1553-1559

Published Date: 22 June 2015

Roles of dopamine receptors and their antagonist thioridazine in hepatoma metastasis

Lu M, Li J, Luo Z, Zhang S, Xue S, Wang K, Shi Y, Zhang C, Chen H, Li Z

OncoTargets and Therapy 2015, 8:1543-1552

Published Date: 22 June 2015

Detection of epidermal growth factor receptor mutation in lung cancer by droplet digital polymerase chain reaction

Xu Q, Zhu Y, Bai Y, Wei X, Zheng X, Mao M, Zheng G

OncoTargets and Therapy 2015, 8:1533-1541

Published Date: 22 June 2015

Anterior gradient protein 3 is associated with less aggressive tumors and better outcome of breast cancer patients

Obacz J, Brychtova V, Podhorec J, Fabian P, Dobes P, Vojtesek B, Hrstka R

OncoTargets and Therapy 2015, 8:1523-1532

Published Date: 24 June 2015

Evaluation of the pathological response and prognosis following neoadjuvant chemotherapy in molecular subtypes of breast cancer

Zhao Y, Dong XQ, Li RG, Ma X, Song J, Li YJ, Zhang DW

OncoTargets and Therapy 2015, 8:1511-1521

Published Date: 19 June 2015

Axillary and internal mammary sentinel lymph node biopsy in male breast cancer patients: case series and review

Cao X, Wang C, Liu Y, Qiu P, Cong B, Wang Y

OncoTargets and Therapy 2015, 8:1499-1502

Published Date: 17 June 2015

IL-27 rs153109 polymorphism increases the risk of colorectal cancer in Chinese Han population

Lyu SX, Ye LC, Wang OC, Huang GL, Yang F, Liu YH, Dong SY

OncoTargets and Therapy 2015, 8:1493-1497

Published Date: 16 June 2015

Exploration of peptide T7 and its derivative as integrin αvβ3-targeted imaging agents

He X, Hao Y, Long W, Song N, Fan S, Meng A

OncoTargets and Therapy 2015, 8:1483-1491

Published Date: 15 June 2015

Prognostic role of HOTAIR in four estrogen-dependent malignant tumors: a meta-analysis

Li J, Wen W, Zhao S, Wang JX, Chen JY, Wang YR, Zhang QY

OncoTargets and Therapy 2015, 8:1471-1482

Published Date: 15 June 2015

CpG oligodeoxyribonucleotide 7909 enhances radiosensitivity via downregulating Oct-4 expression in radioresistant lung cancer cells

Xing N, Qiao T, Zhuang X, Yuan S, Zhang Q, Xu G

OncoTargets and Therapy 2015, 8:1443-1449

Published Date: 12 June 2015

Analysis of clinical efficacy of CyberKnife® treatment for locally advanced pancreatic cancer

Song YC, Yuan ZY, Li FT, Dong Y, Zhuang HQ, Wang JS, Chen HM, Wang P

OncoTargets and Therapy 2015, 8:1427-1431

Published Date: 12 June 2015

Extracellular matrix as target for antitumor therapy

Harisi R, Jeney A

OncoTargets and Therapy 2015, 8:1387-1398

Published Date: 9 June 2015

A comparison of the prognostic value of preoperative inflammation-based scores and TNM stage in patients with gastric cancer

Pan QX, Su ZJ, Zhang JH, Wang CR, Ke SY

OncoTargets and Therapy 2015, 8:1375-1385

Published Date: 16 June 2015

Axitinib versus sorafenib as a second-line therapy in Asian patients with metastatic renal cell carcinoma: results from a randomized registrational study

Qin S, Bi F, Jin J, Cheng Y, Guo J, Ren X, Huang Y, Tarazi J, Tang J, Chen C, Kim S, Ye D

OncoTargets and Therapy 2015, 8:1363-1373

Published Date: 8 June 2015

An active treatment of lung adenocarcinoma cancer with brain metastases: icotinib

Zhang Y, Tang HP, Li J, Li M

OncoTargets and Therapy 2015, 8:1351-1354

Published Date: 8 June 2015

Adjuvant treatment in patients at high risk of recurrence of thymoma: efficacy and safety of a three-dimensional conformal radiation therapy regimen

Perri F, Pisconti S, Conson M, Pacelli R, Della Vittoria Scarpati G, Gnoni A, D’Aniello C, Cavaliere C, Licchetta A, Cella L, Giuliano M, Schiavone C, Falivene S, Di Lorenzo G, Buonerba C, Ravo V, Muto P

OncoTargets and Therapy 2015, 8:1345-1349

Published Date: 8 June 2015

Could erlotinib treatment lead to acute cardiovascular events in patients with lung adenocarcinoma after chemotherapy failure?

Kus T, Aktas G, Sevinc A, Kalender ME, Camci C

OncoTargets and Therapy 2015, 8:1341-1343

Published Date: 5 June 2015

The role of Nanog expression in tamoxifen-resistant breast cancer cells

Arif K, Hussain I, Rea C, El-Sheemy M

OncoTargets and Therapy 2015, 8:1327-1334

Published Date: 3 June 2015

Alectinib for choroidal metastasis in a patient with crizotinib-resistant ALK rearranged positive non-small cell lung cancer

Okuma Y, Tanaka Y, Kamei T, Hosomi Y, Okamura T

OncoTargets and Therapy 2015, 8:1321-1325

Published Date: 3 June 2015

Bevacizumab plus cisplatin and helical tomotherapy in treatment of locally advanced nasopharyngeal carcinoma

Li JX, Zhao ZF, Wu X, Yao J, Ma L, Ye R, Niu BL, Liang LQ, Zhao X, Wang QQ

OncoTargets and Therapy 2015, 8:1315-1319

Published Date: 2 June 2015

Sudden bilateral hearing loss in gastric cancer as the only symptom of disease

Rakusic Z, Misir Krpan A, Stupin Polancec D, Jakovcevic A, Bisof V

OncoTargets and Therapy 2015, 8:1285-1289

Published Date: 2 June 2015

Hyperthermia combined with 5-fluorouracil promoted apoptosis and enhanced thermotolerance in human gastric cancer cell line SGC-7901

Liu T, Ye YW, Zhu AL, Yang Z, Fu Y, Wei CQ, Liu Q, Zhao CL, Wang GJ, Zhang XF

OncoTargets and Therapy 2015, 8:1265-1270

Published Date: 27 May 2015

The clinical significances of the abnormal expressions of Piwil1 and Piwil2 in colonic adenoma and adenocarcinoma

Wang HL, Chen BB, Cao XG, Wang J, Hu, XF, Mu XQ, Chen XB

OncoTargets and Therapy 2015, 8:1259-1264

Published Date: 27 May 2015

Clinical and pathological analysis of 116 cases of adult adrenal cortical adenoma and literature review

Jia AH, Du HQ, Fan MH, Li YH, Xu JL, Niu GF, Bai J, Zhang GZ, Ren YB

OncoTargets and Therapy 2015, 8:1251-1257

Published Date: 28 May 2015

Percutaneous microwave ablation combined with simultaneous transarterial chemoembolization for the treatment of advanced intrahepatic cholangiocarcinoma

Yang GW, Zhao Q, Qian S, Zhu L, Qu XD, Zhang W, Yan ZP, Cheng JM, Liu QX, Liu R, Wang JH

OncoTargets and Therapy 2015, 8:1245-1250

Published Date: 26 May 2015

Positive feedback between oncogenic KRAS and HIF-1α confers drug resistance in colorectal cancer

Wang Y, Lei F, Rong W, Zeng Q, Sun W

OncoTargets and Therapy 2015, 8:1229-1237

Published Date: 26 May 2015

Clinical analysis of 50 Eastern Asian patients with primary pulmonary large-cell neuroendocrine carcinoma

Zhang XK, Qin T, Zeng YD, Zhao YY, Hou X, Fang WF, Hong SD, Zhou T, Hu ZH, Yang YP, Ma YX, Xue C, Huang Y, Zhao HY, Zhang L

OncoTargets and Therapy 2015, 8:1219-1227

Published Date: 26 May 2015

Antiproliferative effects and molecular mechanisms of troglitazone in human cervical cancer in vitro

Ye J, Yin L, Xie P, Wu J, Huang J, Zhou G, Xu H, Lu E, He X

OncoTargets and Therapy 2015, 8:1211-1218

Published Date: 26 May 2015

Oral treatment with the herbal formula B307 alleviates cardiac toxicity in doxorubicin-treated mice via suppressing oxidative stress, inflammation, and apoptosis

Lien CY, Chuang TY, Hsu CH, Lin CL, Wang SE, Sheu SJ, Chien CT, Wu CH

OncoTargets and Therapy 2015, 8:1193-1210

Published Date: 26 May 2015

HGF and NRG1 protein expression are not poor prognostic markers in surgically resected lung adenocarcinoma

Pan B, Wang R, Huang YL, Garfield D, Zhang J, Chen HQ

OncoTargets and Therapy 2015, 8:1185-1191

Published Date: 25 May 2015

DDMC-p53 gene therapy with or without cisplatin and microwave ablation

Hohenforst-Schmidt W, Zarogoulidis P, Stopek J, Vogl T, Hübner F, Turner JF, Browning R, Zarogoulidis K, Drevelegas A, Drevelegas K, Darwiche K, Freitag L, Rittger H

OncoTargets and Therapy 2015, 8:1165-1173

Published Date: 20 May 2015

The prognostic significance of fibroblast growth factor receptor 4 in non-small-cell lung cancer

Huang H, Feng H, Qiao H, Ren Z, Zhu G

OncoTargets and Therapy 2015, 8:1157-1164

Published Date: 22 May 2015

Tracking the 2015 Gastrointestinal Cancers Symposium: bridging cancer biology to clinical gastrointestinal oncology

Aprile G, Leone F, Giampieri R, Casagrande M, Marino D, Faloppi L, Cascinu S, Fasola G, Scartozzi M

OncoTargets and Therapy 2015, 8:1149-1156

Published Date: 22 May 2015

Anaplastic lymphoma kinase-positive anaplastic large-cell lymphoma with involvement of the urinary bladder: a case report and review of literature

Liang X, Wang Y, Zhang J, Cheng H, Wang J, Dang Y, Li H, Zhou R, Zhang J, Qiao Q

OncoTargets and Therapy 2015, 8:1143-1147

Published Date: 19 May 2015

Perioperative FOLFOX4 plus bevacizumab for initially unresectable advanced colorectal cancer (NAVIGATE-CRC-01)

Suenaga M, Fujimoto Y, Matsusaka S, Shinozaki E, Akiyoshi T, Nagayama S, Fukunaga Y, Oya M, Ueno M, Mizunuma N, Yamaguchi T

OncoTargets and Therapy 2015, 8:1111-1118

Published Date: 18 May 2015

Radium-223 for the treatment of castration-resistant prostate cancer

El-Amm J, Aragon-Ching JB

OncoTargets and Therapy 2015, 8:1103-1109

Published Date: 18 May 2015

Comparison of tumor markers using different detection devices

Tao R, Tu SH, Liu C, Yang Q, Zhu M, Shen JF

OncoTargets and Therapy 2015, 8:1083-1090

Published Date: 19 May 2015

Circulating VEGF as a biomarker for diagnosis of ovarian cancer: a systematic review and a meta-analysis

Liang B, He Q, Zhong L, Wang S, Pan Z, Wang T, Zhao Y

OncoTargets and Therapy 2015, 8:1075-1082

Published Date: 15 May 2015

Primary paraesophageal Ewing’s sarcoma: an uncommon case report and literature review

Tarazona N, Navarro L, Cejalvo JM, Gambardella V, Pérez-Fidalgo JA, Sempere A, Navarro S, Cervantes A

OncoTargets and Therapy 2015, 8:1053-1059

Published Date: 14 May 2015

Lung cancer drug therapy in Hungary – 3-year experience

Moldvay J, Rokszin G, Abonyi-Tóth Z, Katona L, Fábián K, Kovács G

OncoTargets and Therapy 2015, 8:1031-1038

Published Date: 11 May 2015

Evaluation of clinical breast examination and breast ultrasonography among pregnant women in Abakaliki, Nigeria

Ezeonu PO, Ajah LO, Onoh RC, Lawani LO, Enemuo VC, Agwu UM

OncoTargets and Therapy 2015, 8:1025-1029

Published Date: 13 May 2015

ABCB1 C3435T polymorphism is associated with leukemia susceptibility: evidence from a meta-analysis

Ma L, Ruan L, Liu H, Yang H, Feng Y

OncoTargets and Therapy 2015, 8:1009-1015

Published Date: 5 May 2015

Impact of beta-blockers on prostate cancer mortality: a meta-analysis of 16,825 patients

Lu H, Liu XJ, Guo FF, Tan SF, Wang GJ, Liu HJ, Wang JM, He XF, Mo YS, Shi BK

OncoTargets and Therapy 2015, 8:985-990

Published Date: 30 April 2015

SIRT1 expression is associated with poor prognosis of lung adenocarcinoma

Li C, Wang L, Zheng L, Zhan X, Xu B, Jiang J, Wu C

OncoTargets and Therapy 2015, 8:977-984

Published Date: 30 April 2015

Evaluation and comparison of two commercially available targeted next-generation sequencing platforms to assist oncology decision making

Weiss GJ, Hoff BR, Whitehead RP, Sangal A, Gingrich SA, Penny RJ, Mallery DW, Morris SM, Thompson EJ, Loesch DM, Khemka V

OncoTargets and Therapy 2015, 8:959-967

Published Date: 24 April 2015

Effect of blood type on survival of Chinese patients with esophageal squamous cell carcinoma

Qin J, Wu SG, Sun JY, Lin HX, He ZY, Li Q

OncoTargets and Therapy 2015, 8:947-953

Published Date: 23 April 2015

Randomized Phase II trial of paclitaxel plus valproic acid vs paclitaxel alone as second-line therapy for patients with advanced gastric cancer

Fushida S, Kaji M, Oyama K, Hirono Y, Nezuka H, Takeda T, Tsukada T, Fujimoto D, Ohyama S, Fujimura T, Ohta T

OncoTargets and Therapy 2015, 8:939-941

Published Date: 23 April 2015

Pilot study investigating the prognostic significance of thymidine phosphorylase expression in patients with metastatic breast cancer: a single institution retrospective analysis

Tedeschi AL, Eslami Z, Garoufalis E, Saleh RR, Omeroglu A, Altinel G, Ait-Tihyaty M, Jean-Claude B, Mihalcioiu C

OncoTargets and Therapy 2015, 8:911-919

Published Date: 21 April 2015

Comparison of uncommon EGFR exon 21 L858R compound mutations with single mutation

Peng L, Song ZG, Jiao SC

OncoTargets and Therapy 2015, 8:905-910

Published Date: 21 April 2015

HES1 is an independent prognostic factor for acute myeloid leukemia

Tian C, Tang Y, Wang T, Yu Y, Wang X, Wang Y, Zhang Y

OncoTargets and Therapy 2015, 8:899-904

Published Date: 22 April 2015

Comparison of single-agent chemotherapy and targeted therapy to first-line treatment in patients aged 80 years and older with advanced non-small-cell lung cancer

Zhang QQ, Wang ZH, Guo J, Liu LY, Han X, Li MM, Fang S, Bi X, Tang N, Liu Y

OncoTargets and Therapy 2015, 8:893-898

Published Date: 20 April 2015

Novel targeted therapies for resistant ALK-rearranged non-small-cell lung cancer: ceritinib and beyond

Kanaan Z, Kloecker GH, Paintal A, Perez CA

OncoTargets and Therapy 2015, 8:885-892

Published Date: 20 April 2015

Synergistic inhibition of colon carcinoma cell growth by Hedgehog-Gli1 inhibitor arsenic trioxide and phosphoinositide 3-kinase inhibitor LY294002

Cai X, Yu K, Zhang L, Li Y, Li Q, Yang Z, Shen T, Duan L, Xiong W, Wang W

OncoTargets and Therapy 2015, 8:877-883

Published Date: 17 April 2015

Enzalutamide for patients with metastatic castration-resistant prostate cancer

Ramadan WH, Kabbara WK, Al Basiouni Al Masri HS

OncoTargets and Therapy 2015, 8:871-876

Published Date: 17 April 2015

Outcome of surgical resection for brain metastases and radical treatment of the primary tumor in Chinese non–small-cell lung cancer patients

Li Z, Zhang X, Jiang X, Guo C, Sai K, Yang Q, He Z, Wang Y, Chen Z, Li W, Mou Y

OncoTargets and Therapy 2015, 8:855-860

Published Date: 16 April 2015

Artesunate inhibits the growth and induces apoptosis of human gastric cancer cells by downregulating COX-2

Zhang P, Luo HS, Li M, Tan SY

OncoTargets and Therapy 2015, 8:845-854

Published Date: 16 April 2015

The significance of combining VEGFA, FLT1, and KDR expressions in colon cancer patient prognosis and predicting response to bevacizumab

Zhang SD, McCrudden CM, Meng C, Lin Y, Kwok HF

OncoTargets and Therapy 2015, 8:835-843

Published Date: 15 April 2015

DNA ploidy of cervical epithelial cells should be a cure criterion of high-risk HPV infection in Xinjiang Uygur women

Feng YC, Yang J, Liu CM, Cheng ZZ, Huang YC

OncoTargets and Therapy 2015, 8:827-833

Published Date: 13 April 2015

Profile of nimotuzumab in the treatment of high-grade glioma

Yang Q, Guo C, Chen Z

OncoTargets and Therapy 2015, 8:819-825

Published Date: 13 April 2015

Prognostic significance of neutrophil-to-lymphocyte ratio in esophageal cancer: a meta-analysis

Yang X, Huang Y, Feng JF, Liu JS

OncoTargets and Therapy 2015, 8:789-794

Published Date: 10 April 2015

The effects of PGC-1α on the proliferation and energy metabolism of malignant endometrial cancer cells

Ren Z, Yang H, Wang C, Ma X

OncoTargets and Therapy 2015, 8:769-774

Published Date: 9 April 2015

GSK1838705A, an insulin-like growth factor-1 receptor/insulin receptor inhibitor, induces apoptosis and reduces viability of docetaxel-resistant prostate cancer cells both in vitro and in vivo

Zhou F, Chen X, Fan S, Tai S, Jiang C, Zhang Y, Hao Z, Zhou J, Shi H, Zhang L, Liang C

OncoTargets and Therapy 2015, 8:753-760

Published Date: 10 April 2015

Gene expression profile analysis of colorectal cancer to investigate potential mechanisms using bioinformatics

Kou YB, Zhang SY, Chen XP, Hu SY

OncoTargets and Therapy 2015, 8:745-752

Published Date: 8 April 2015

Adipose tissue-secreted miR-27a promotes liver cancer by targeting FOXO1 in obese individuals

Sun B, Li J, Shao D, Pan Y, Chen Y, Li S, Yao X, Li H, Liu W, Zhang M, Zhang X, Chen L

OncoTargets and Therapy 2015, 8:735-744

Published Date: 7 April 2015

A chromosomal passenger complex protein signature model predicts poor prognosis for non-small-cell lung cancer

Xia R, Chen S, Chen Y, Zhang W, Zhu R, Deng A

OncoTargets and Therapy 2015, 8:721-726

Published Date: 7 April 2015

Development of a preliminary nomogram to predict progression of bone scan for castration-resistant prostate cancer

Lin GW, Ye DW, Jia HX, Dai B, Zhang HL, Zhu Y, Shi GH, Ma CG

OncoTargets and Therapy 2015, 8:713-719

Published Date: 7 April 2015

Treatment and prognosis of Masaoka stage 3 thymic carcinoma: a retrospective study of 32 cases

Sun Y, Liu J, Yu X

OncoTargets and Therapy 2015, 8:699-702

Published Date: 6 April 2015

A clinical and radiological objective tumor response with somatostatin analogs (SSA) in well-differentiated neuroendocrine metastatic tumor of the ileum: a case report

De Divitiis C, von Arx C, Carbone R, Tatangelo F, Di Girolamo E, Romano GM, Ottaiano A, de Lutio di Castelguidone E, Iaffaioli RV, Tafuto S

OncoTargets and Therapy 2015, 8:669-675

Published Date: 31 March 2015

Protective effect of gonadotropin-releasing hormone analog on the ovarian reserve in rats receiving cyclophosphamide treatment

Gui T, Yuan GW, Shen K, Cao DY, Yang JX, Wu M, Lang JH

OncoTargets and Therapy 2015, 8:661-667

Published Date: 23 March 2015

Clinical significance of ALDH2 rs671 polymorphism in esophageal cancer: evidence from 31 case-control studies

Zhao TT, Wang C, Shen LL, Gu DY, Xu Z, Zhang XL, Xu Y, Chen JF

OncoTargets and Therapy 2015, 8:649-659

Published Date: 23 March 2015

Elevated expression of NEDD9 is associated with metastatic activity in gastric cancer

Zhang SS, Wu LH, Liu Q, Chen KS, Zhang XF

OncoTargets and Therapy 2015, 8:633-640

Published Date: 10 March 2015

Early enteral and parenteral nutritional support after hepatectomy in patients with hepatic carcinoma: a systematic review and meta-analysis

Gao LB, Tian H, Wang XG, Yu XF, Guan Y, Chen ML, Zhang J

OncoTargets and Therapy 2015, 8:623-631

Published Date: 10 March 2015

Expression and clinical significance of fibroblast growth factor 1 in gastric adenocarcinoma

Liu NQ, Zhang JG, Sun SX, Yang LG, Zhou ZJ, Sun QL, Niu J

OncoTargets and Therapy 2015, 8:615-621

Published Date: 9 March 2015

The association between the migration inhibitory factor -173G/C polymorphism and cancer risk: a meta-analysis

Zhang X, Weng WH, Xu W, Wang YL, Yu WJ, Tang X, Ma LF, Pan QH, Wang JY, Sun FY

OncoTargets and Therapy 2015, 8:601-613

Published Date: 10 March 2015

Transcatheter arterial chemoembolization with gemcitabine and oxaliplatin for the treatment of advanced biliary tract cancer

Zhao Q, Qian S, Zhu L, Qu XD, Zhang W, Yan ZP, Cheng JM, Liu QX, Liu R, Wang JH

OncoTargets and Therapy 2015, 8:595-600

Published Date: 9 March 2015

Outcomes analysis of an alternative formulation of PEGylated liposomal doxorubicin in recurrent epithelial ovarian carcinoma during the drug shortage era [Corrigendum]

Berger JL, Smith A, Zorn KK, Sukumvanich P, Olawaiye AB, Kelley J, Krivak TC

OncoTargets and Therapy 2015, 8:593-594

Published Date: 9 March 2015

Epoetin beta for the treatment of chemotherapy-induced anemia: an update

Galli L, Ricci C, Egan CG

OncoTargets and Therapy 2015, 8:583-591

Published Date: 5 March 2015

Human papillomavirus 16 infection predicts poor outcome in patients with esophageal squamous cell carcinoma

Xi R, Zhang X, Chen X, Pan S, Hui B, Zhang L, Fu S, Li X, Zhang X, Gong T, Guo J, Che S

OncoTargets and Therapy 2015, 8:573-581

Published Date: 5 March 2015

Accumulation of p53 is prognostic for aromatase inhibitor resistance in early-stage postmenopausal patients with ER-positive breast cancer

Jia XQ, Hong Q, Cheng JY, Li JW, Wang YJ, Mo M, Shao ZM, Shen ZZ, Liu GY

OncoTargets and Therapy 2015, 8:549-555

Published Date: 3 March 2015

The role of miR-29b in cancer: regulation, function, and signaling

Yan B, Guo Q, Fu FJ, Wang Z, Yin Z, Wei YB, Yang JR

OncoTargets and Therapy 2015, 8:539-548

Published Date: 3 March 2015

Comparison between three oxaliplatin-based regimens with bevacizumab in patients with metastatic colorectal cancer

Ohhara Y, Suenaga M, Matsusaka S, Shinozaki E, Mizunuma N, Yamaguchi T

OncoTargets and Therapy 2015, 8:529-537

Published Date: 3 March 2015

An update on PARP inhibitors for the treatment of cancer

Benafif S, Hall M

OncoTargets and Therapy 2015, 8:519-528

Published Date: 26 February 2015

Nimotuzumab abrogates acquired radioresistance of KYSE-150R esophageal cancer cells by inhibiting EGFR signaling and cellular DNA repair

Liu H, Yang W, Gao H, Jiang T, Gu B, Dong Q, Xu W, Wu S, Sun X

OncoTargets and Therapy 2015, 8:509-518

Published Date: 25 February 2015

Cell death in response to antimetabolites directed at ribonucleotide reductase and thymidylate synthase

Asuncion Valenzuela MM, Castro I, Gonda A, Diaz Osterman CJ, Jutzy JM, Aspe JR, Khan S, Neidigh JW, Wall NR

OncoTargets and Therapy 2015, 8:495-507

Published Date: 26 February 2015

Validation of the Memorial Sloan Kettering Cancer Center nomogram for predicting non-sentinel lymph node metastasis in sentinel lymph node-positive breast-cancer patients

Bi X, Wang Y, Li M, Chen P, Zhou Z, Liu Y, Zhao T, Zhang Z, Wang C, Sun X, Qiu P

OncoTargets and Therapy 2015, 8:487-493

Published Date: 23 February 2015

Assessment of selected cytokines, proteins, and growth factors in the peritoneal fluid of patients with ovarian cancer and benign gynecological conditions

Chudecka-Głaz AM, Cymbaluk-Płoska AA, Menkiszak JL, Pius-Sadowska E, Machaliński BB, Sompolska-Rzechuła A, Rzepka-Górska IA

OncoTargets and Therapy 2015, 8:471-485

Published Date: 23 February 2015

Epigallocatechin-3-gallate suppresses cell proliferation and promotes apoptosis and autophagy in oral cancer SSC-4 cells

Irimie AI, Braicu C, Zanoaga O, Pileczki V, Gherman C, Berindan-Neagoe I, Campian RS

OncoTargets and Therapy 2015, 8:461-470

Published Date: 20 February 2015

Astroblastoma: beside being a tumor entity, an occasional phenotype of astrocytic gliomas?

Mellai M, Piazzi A, Casalone C, Grifoni S, Melcarne A, Annovazzi L, Cassoni P, Denysenko T, Valentini MC, Cistaro A, Schiffer D

OncoTargets and Therapy 2015, 8:451-460

Published Date: 19 February 2015

The imaging features of metanephric adenoma: a case report and review of literature

Hu YC, Wu L, Yan LF, Zhang W, Cui GB

OncoTargets and Therapy 2015, 8:445-449

Published Date: 13 February 2015

Multimodality therapy is recommended for limited-stage combined small cell esophageal carcinoma

Wang HH, Zaorsky NG, Meng MB, Wu ZQ, Zeng XL, Jiang B, Jiang C, Zhao LJ, Yuan ZY, Wang P

OncoTargets and Therapy 2015, 8:437-444

Published Date: 13 February 2015

Single-nucleotide polymorphisms of microRNA processing machinery genes and risk of colorectal cancer

Zhao Y, Du Y, Zhao S, Guo Z

OncoTargets and Therapy 2015, 8:421-425

Published Date: 12 February 2015

High mobility group box-1 and its clinical value in breast cancer

Sun S, Zhang W, Cui Z, Chen Q, Xie P, Zhou C, Liu B, Peng X, Zhang Y

OncoTargets and Therapy 2015, 8:413-419

Published Date: 12 February 2015

Use of allogeneic platelet gel in the management of chemotherapy extravasation injuries: a case report

Di Costanzo G, Loquercio G, Marcacci G, Iervolino V, Mori S, Petruzziello A, Barra P, Cacciapuoti C

OncoTargets and Therapy 2015, 8:401-404

Published Date: 9 February 2015

The clue of a possible etiology about spontaneous regression of hepatocellular carcinoma: a perspective on pathology

Wang Z, Ke ZF, Lu XF, Luo CJ, Liu YD, Lin ZW, Wang LT

OncoTargets and Therapy 2015, 8:395-400

Published Date: 5 February 2015

XPA A23G polymorphism and risk of digestive system cancers: a meta-analysis

He L, Deng T, Luo H

OncoTargets and Therapy 2015, 8:385-394

Published Date: 5 February 2015

Novel covalent modification of human anaplastic lymphoma kinase (ALK) and potentiation of crizotinib-mediated inhibition of ALK activity by BNP7787

Parker AR, Petluru PN, Nienaber VL, Zhao M, Ayala PY, Badger J, Chie-Leon B, Sridhar V, Logan C, Kochat H, Hausheer FH

OncoTargets and Therapy 2015, 8:375-383

Published Date: 4 February 2015

The utility of bexarotene in mycosis fungoides and Sézary syndrome

Panchal MR, Scarisbrick JJ

OncoTargets and Therapy 2015, 8:367-373

Published Date: 3 February 2015

Disruption of human papillomavirus 16 E6 gene by clustered regularly interspaced short palindromic repeat/Cas system in human cervical cancer cells [Corrigendum]

Yu L, Wang XL, Zhu D, Ding WC, Wang LM, Zhang CL, Jiang XH, Shen H, Liao SJ, Ma D, Hu Z, Wang H

OncoTargets and Therapy 2015, 8:365-366

Published Date: 4 February 2015

MicroRNA-153 acts as a prognostic marker in gastric cancer and its role in cell migration and invasion

Zhang Z, Sun J, Bai Z, Li H, He S, Chen R, Che X

OncoTargets and Therapy 2015, 8:357-364

Published Date: 2 February 2015

Use of transient elastography to predict de novo recurrence after radiofrequency ablation for hepatocellular carcinoma

Lee SH, Kim SU, Jang JW, Bae SH, Lee SH, Kim BK, Park JY, Kim DY, Ahn SH, Han KH

OncoTargets and Therapy 2015, 8:347-356

Published Date: 2 February 2015

Cytotoxic effect of lapatinib is restricted to human papillomavirus-positive head and neck squamous cell carcinoma cell lines

Fumagalli I, Dugue D, Bibault JE, Clémenson C, Vozenin MC, Mondini M, Deutsch E

OncoTargets and Therapy 2015, 8:335-345

Published Date: 2 February 2015

Targeting specificity of dendritic cells on breast cancer stem cells: in vitro and in vivo evaluations

Nguyen ST, Nguyen HL, Pham VQ, Nguyen GT, Tran CD, Phan NK, Pham PV

OncoTargets and Therapy 2015, 8:323-334

Published Date: 30 January 2015

Targeted therapies for renal cell carcinoma in Chinese patients: focus on everolimus

Tan X, Liu Y, Hou J, Cao G

OncoTargets and Therapy 2015, 8:313-321

Published Date: 29 January 2015

Tubeimoside-1 induces glioma apoptosis through regulation of Bax/Bcl-2 and the ROS/Cytochrome C/Caspase-3 pathway

Jia G, Wang Q, Wang R, Deng D, Xue L, Shao N, Zhang Y, Xia X, Zhi F, Yang Y

OncoTargets and Therapy 2015, 8:303-311

Published Date: 30 January 2015

In vivo DNA damaging and apoptotic potential of silver nanoparticles in Swiss albino mice

Al Gurabi MA, Ali D, Alkahtani S, Alarifi S

OncoTargets and Therapy 2015, 8:295-302

Published Date: 29 January 2015

Efficacy of nab-paclitaxel plus trastuzumab in a long-surviving heavily pretreated HER2-positive breast cancer patient with brain metastases

Ricciardi GRR, Russo A, Franchina T, Ferraro G, Adamo V

OncoTargets and Therapy 2015, 8:289-294

Published Date: 2 February 2015

The impact of IGF-1R expression on the outcomes of patients with breast cancer: a meta-analysis

Yan S, Jiao X, Li K, Li W, Zou H

OncoTargets and Therapy 2015, 8:279-287

Published Date: 29 January 2015

NVP-BEZ235 overcomes gefitinib-acquired resistance by down-regulating PI3K/AKT/ mTOR phosphorylation

Sun ZH, Li QH, Zhang S, Chen J, Huang LL, Ren JH, Chang Y, Liang YC, Wu G

OncoTargets and Therapy 2015, 8:269-277

Published Date: 29 January 2015

Primary malignant lymphoma of the uterus and broad ligament: a case report and review of literature

Chen R, Yu Z, Zhang H, Ding J, Chen B

OncoTargets and Therapy 2015, 8:265-268

Published Date: 29 January 2015

Changes in sebum levels and the development of acneiform rash in patients with non–small cell lung cancer after treatment with EGFR inhibitors

Nakahara T, Moroi Y, Takayama K, Itoh E, Kido-Nakahara M, Nakanishi Y, Furue M

OncoTargets and Therapy 2015, 8:259-263

Published Date: 28 January 2015

Anticoagulant therapy for venous thromboembolism detected by Doppler ultrasound in patients with metastatic colorectal cancer receiving bevacizumab

Suenaga M, Mizunuma N, Shinozaki E, Matsusaka S, Ozaka M, Ogura M, Chin K, Yamaguchi T

OncoTargets and Therapy 2015, 8:243-249

Published Date: 27 January 2015

Tumor deposit is a poor prognostic indicator in patients who underwent simultaneous resection for synchronous colorectal liver metastases

Lin Q, Wei Y, Ren L, Zhong Y, Qin C, Zheng P, Xu P, Zhu D, Ji M, Xu J

OncoTargets and Therapy 2015, 8:233-240

Published Date: 22 January 2015

Impact on growth and invasion of gastric cancer cell lines by silencing NEDD9

Zhang SS, Wu LH, Liu Q, Chen KS, Zhang XF

OncoTargets and Therapy 2015, 8:223-231

Published Date: 20 January 2015

Meta-analysis of the association between APC promoter methylation and colorectal cancer

Ding ZY, Jiang T, Piao Y, Han T, Han YL, Xie XD

OncoTargets and Therapy 2015, 8:211-222

Published Date: 19 January 2015

Oncogenic mutation profiling in new lung cancer and mesothelioma cell lines

Lam DC, Luo SY, Deng W, Kwan JS, Rodriguez-Canales J, Cheung AL, Cheng GH, Lin CH, Wistuba II, Sham PC, Wan TS, Tsao SW

OncoTargets and Therapy 2015, 8:195-209

Published Date: 16 January 2015

Triple-negative breast cancer: new perspectives for targeted therapies

Tomao F, Papa A, Zaccarelli E, Rossi L, Caruso D, Minozzi M, Vici P, Frati L, Tomao S

OncoTargets and Therapy 2015, 8:177-193

Published Date: 16 January 2015

HMGA2 is associated with epithelial–mesenchymal transition and can predict poor prognosis in nasopharyngeal carcinoma

Xia YY, Yin L, Tian H, Guo WJ, Jiang N, Jiang XS, Wu J, Chen M, Wu JZ, He X

OncoTargets and Therapy 2015, 8:169-176

Published Date: 17 January 2015

BRAF-mutant melanoma: treatment approaches, resistance mechanisms, and diagnostic strategies

Spagnolo F, Ghiorzo P, Orgiano L, Pastorino L, Picasso V, Tornari E, Ottaviano V, Queirolo P

OncoTargets and Therapy 2015, 8:157-168

Published Date: 16 January 2015

Prognostic role of apoptosis-related gene functional variants in advanced non-small-cell lung cancer patients treated with first-line platinum-based chemotherapy

Tao KY, Li XX, Xu WZ, Wang Y, Zhu SM, Xie HX, Luo WH, Xu YJ, Xu XL

OncoTargets and Therapy 2015, 8:147-155

Published Date: 14 January 2015

Advances in the targeted therapy of liposarcoma

Guan Z, Yu X, Wang H, Wang H, Zhang J, Li G, Cao J, Teng L

OncoTargets and Therapy 2015, 8:125-136

Published Date: 5 January 2015

Clinical and epidemiological study of EGFR mutations and EML4-ALK fusion genes among Indian patients with adenocarcinoma of the lung

Doval DC, Prabhash K, Patil S, Chaturvedi H, Goswami C, Vaid AK, Desai S, Dutt S, Veldore VH, Jambhekar N, Mehta A, Hazarika D, Azam S, Gawande S, Gupta S

OncoTargets and Therapy 2015, 8:117-123

Published Date: 5 January 2015

Ethanol extracts of Cinnamomum kanehirai Hayata leaves induce apoptosis in human hepatoma cell through caspase-3 cascade

Liu YK, Chen KH, Leu YL, Way TD, Wang LW, Chen YJ, Liu YM

OncoTargets and Therapy 2015, 8:99-109

Published Date: 31 December 2014

Breast metastases of gastric signet-ring cell carcinoma: a report of two cases and review of the literature

Iesato A, Oba T, Ono M, Hanamura T, Watanabe T, Ito T, Kanai T, Maeno K, Ishizaka K, Kitabatake H, Takeuchi D, Suzuki A, Nakayama J, Ito K

OncoTargets and Therapy 2015, 8:91-97

Published Date: 29 December 2014

Decreased expression of APAF-1 and increased expression of cathepsin B in invasive pituitary adenoma

Tanase C, Albulescu R, Codrici E, Calenic B, Popescu ID, Mihai S, Necula L, Cruceru ML, Hinescu ME

OncoTargets and Therapy 2015, 8:81-90

Published Date: 22 December 2014

The landscape of alternative splicing in cervical squamous cell carcinoma

Guo P, Wang D, Wu J, Yang J, Ren T, Zhu B, Xiang Y

OncoTargets and Therapy 2015, 8:73-79

Published Date: 22 December 2014

Disruption of human papillomavirus 16 E6 gene by clustered regularly interspaced short palindromic repeat/Cas system in human cervical cancer cells

Yu L, Wang XL, Zhu D, Ding WC, Wang LM, Zhang CL, Jiang XH, Shen H, Liao SJ, Ma D, Hu Z, Wang H

OncoTargets and Therapy 2015, 8:37-44

Published Date: 22 December 2014

Lumbosacral plexus delineation, dose distribution, and its correlation with radiation-induced lumbosacral plexopathy in cervical cancer patients

Tunio M, Al Asiri M, Bayoumi Y, Abdullah O Balbaid A, AlHameed M, Gabriela SL, Amir O Ali A

OncoTargets and Therapy 2015, 8:21-27

Published Date: 23 December 2014

Neoadjuvant hormone therapy following treatment with robotic-assisted radical prostatectomy achieved favorable in high-risk prostate cancer

Hou CP, Lee WC, Lin YH, Chen SM, Chen CL, Chang PL, Juang HH, Tsui KH

OncoTargets and Therapy 2015, 8:15-19

Published Date: 17 December 2014

Assessment and prognostic analysis of EGFR, HER2, and HER3 protein expression in surgically resected gastric adenocarcinomas

Tang D, Liu YJ, Shen D, Fan S, Su X, Ye P, Gavine PR, Yin X

OncoTargets and Therapy 2015, 8:7-14

Published Date: 16 December 2014

Efficacy of sorafenib in advanced differentiated and medullary thyroid cancer: experience in a Turkish population

Benekli M, Yalcin S, Ozkan M, Elkiran ET, Sevinc A, Cabuk D, Coskun HS, Oksuzoglu B, Bayar B, Akbulat A, Ozet A

OncoTargets and Therapy 2015, 8:1-5

Published Date: 15 December 2014